Stock NOT NOVARTIS AG
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Novartis AG Xetra

Equities

NOT

CH0012005267

Chart calendar Novartis AG

c3e7398ca36b03eca3c949d7bbb4ff1.PlOvcm0atLg8KiKZ8Nw9iYr8Ueuf0--xN7m-25uT5j8.fT7eLSxJztR3aFD8gqxi-cOmCZH-gsLQQ-vUrN_w0kxTOfUqCC-BgVASGg~323d728f63b11176eb7e0f03216e8bba

Upcoming events on Novartis AG

2024-05-22 Deutsche Bank dbAccess European Champions Conference
2024-06-01 ASCO Meeting
2024-06-18 Citi European Healthcare Conference
2024-06-19 J.P. Morgan European Healthcare Conference
2024-07-18 01:00 am Q2 2024 Earnings Release
2024-10-29 02:00 am Q3 2024 Earnings Release
2024-11-19 Investor Meeting - Day 1
2024-11-20 Investor Meeting - Day 2
2025-01-28 Q4 2024 Earnings Release (Projected)
2025-04-28 Q1 2025 Earnings Release (Projected)
2025-07-16 Q2 2025 Earnings Release (Projected)
2025-10-27 Q3 2025 Earnings Release (Projected)

Past events on Novartis AG

2024-04-23 08:00 am Q1 2024 Earnings Call
2024-04-23 01:00 am Q1 2024 Earnings Release
2024-03-06 Ex-dividend day for final dividend
2024-03-04 Annual General Meeting
2024-03-02 Muscular Dystrophy Association Clinical and Scientific Conference
2024-01-31 08:00 am Q4 2023 Earnings Call
2024-01-31 01:00 am Q4 2023 Earnings Release
2024-01-08 11:35 am JPMorgan Healthcare Conference
2023-12-07 San Antonio Breast Cancer Symposium
2023-11-28 08:30 am R&D Day
2023-11-14 Wolfe Research Healthcare Conference
2023-11-14 UBS European Conference
2023-11-13 Credit Suisse Healthcare Conference
2023-11-13 10:30 am Impact and Health Equity Conference
2023-11-07 UBS BioPharma Conference
2023-10-24 08:00 am Q3 2023 Earnings Call
2023-10-24 07:00 am ESMO Congress
2023-10-24 01:00 am Q3 2023 Earnings Release
2023-10-23 11:10 am ESMO Congress
2023-10-03 Spin off

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		47 445
47 897
-0.94%		48 659
49 074
-0.85%		51 626
51 902
-0.53%		50 545
51 352
-1.57%		45 440
46 810
-2.93%
48 664

EBITDA
Million USD		Released
Forecast
Spread 		15 809
15 640
1.08%		16 845
16 496
2.12%		18 246
18 336
-0.49%		18 613
17 036
9.25%		17 937
18 223
-1.57%
19 138

EBIT
Million USD		Released
Forecast
Spread 		14 112
14 152
-0.28%		15 416
15 540
-0.8%		16 588
16 712
-0.74%		16 665
16 417
1.51%		16 372
16 735
-2.17%
17 948

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		8 940
9 963
-10.27%		9 878
10 184
-3%		26 137
18 886
38.39%		8 371
10 562
-20.74%		9 123
10 323
-11.63%
12 533

Net income
Million USD		Released
Forecast
Spread 		7 147
8 481
-15.73%		8 072
8 392
-3.81%		24 021
23 336
2.93%		6 955
8 563
-18.78%		14 854
10 329
43.8%
10 231

EPS
USD		Released
Forecast
Spread 		3,12
3,88
-19.63%		3,55
3,68
-3.52%		10,7
10,3
3.79%		3,19
4,06
-21.46%		7,15
5,38
32.95%
5,01

Announcement Date29/01/2026/01/2102/02/2201/02/2331/01/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		12 531
12 640
-0.86%		12 781
12 767
0.11%		12 543
12 737
-1.52%		12 690
13 138
-3.41%		12 953
12 567
3.07%		13 622
13 270
2.65%		11 782
11 373
3.6%		11 423
11 773
-2.97%		11 829
11 498
2.88%
12 200


12 429


12 682


11 905


12 155

EBITDA
Million USD		Released
Forecast
Spread 		4 407
4 039
9.12%		4 989


4 783
3 239
47.69%		4 473
4 104
8.99%


4 668





4 224
4 775
-11.55%

















EBIT
Million USD		Released
Forecast
Spread 		4 083
4 092
-0.23%		4 270
4 159
2.67%		4 282
4 237
1.06%		4 030
3 741
7.71%		4 413
4 078
8.22%		4 668
4 446
5%		4 405
4 339
1.52%		3 821
4 094
-6.66%		4 537
4 220
7.52%
4 565


4 673


4 503


4 790


4 895

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		2 669
2 838
-5.95%		2 042
2 548
-19.86%		1 919
2 619
-26.73%		1 741
2 521
-30.94%		2 740
2 797
-2.04%		2 769
3 194
-13.31%		1 552
3 240
-52.1%		2 377
3 495
-31.99%		3 129
3 453
-9.38%
3 731


3 782


3 495







Net income
Million USD		Released
Forecast
Spread 		2 222
2 313
-3.93%		1 695
2 340
-27.56%		1 575
2 379
-33.79%		1 466
2 919
-49.78%		2 293
2 268
1.1%		2 316
2 596
-10.8%		1 513
2 786
-45.69%		8 480
6 890
23.08%		2 688
2 459
9.31%
2 563


2 609


2 294







EPS
USD		Released
Forecast
Spread 		1,00
1,04
-3.41%		0,77
1,05
-26.4%		0,73
1,17
-37.81%		0,69
1,35
-48.9%		1,09
1,07
1.82%		1,11
1,26
-11.75%		0,73
1,34
-45.68%		4,14
2,87
44.31%		1,31
1,19
10.18%
1,25


1,28


1,13







Announcement Date26/04/2219/07/2225/10/2201/02/2325/04/2318/07/2324/10/2331/01/2423/04/24-----

Upcoming sector events for Novartis AG

2024-04-24 HIKMA PHARMACEUTICALS PLC: Q1 2024 Sales and Revenue Release - Trading Update
2024-04-24 IPSEN: Q1 2024 Sales and Revenue Release
2024-04-24 HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q4 2023 Earnings Release
2024-04-24 CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD: Q1 2024 Earnings Release
2024-04-24 HUNAN JIUDIAN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-24 ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
2024-04-24 OBIO TECHNOLOGY (SHANGHAI) CORP., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 LAURUS LABS LIMITED: Q4 2024 Earnings Release
2024-04-24 PT KALBE FARMA TBK.: Q1 2024 Earnings Release (Projected)
2024-04-24 GLENMARK LIFE SCIENCES LIMITED: Q4 2024 Earnings Release
More events

Past sector events for Novartis AG

Today 01:00 am ROCHE HOLDING AG: Q1 2024 Sales and Revenue Release
Today 08:05 pm NEUREN PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report
Today KINGCHEM (LIAONING) LIFE SCIENCE CO., LTD.: Q1 2024 Earnings Release
Today HANGZHOU MINSHENG HEALTHCARE CO., LTD.: Q4 2023 Earnings Release
Today NEWLAND PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today BEIJING FOYOU PHARMA CO.,LTD: Q1 2024 Earnings Release
Today PHARMABLOCK SCIENCES (NANJING), INC.: Q1 2024 Earnings Release
Today BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.: Q1 2024 Earnings Release (Projected)
Today GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q1 2024 Earnings Release
Today BEIJING SL PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. NOVN Stock
  4. NOT Stock
  5. Calendar Novartis AG